暗記メーカー
ログイン
Neuroendocrine Obesity Pharm
  • Two Clean Queens

  • 問題数 100 • 3/3/2024

    記憶度

    完璧

    15

    覚えた

    35

    うろ覚え

    0

    苦手

    0

    未解答

    0

    アカウント登録して、解答結果を保存しよう

    問題一覧

  • 1

    Review function of HPA axis

    A major neuroendocrine system at controls reactions to stress and regulates many body processes, including digestion, immune responses, mood and emotions, sexual activity, and energy storage and expenditure. It is the common mechanism for interactions among glands, hormones, and parts of the midbrain that mediate the general adaptation syndrome (GAS)

  • 2

    The key elements of the HPA axis are...

    The paraventricular nucleus of the hypothalamus, anterior lobe of the pituitary gland, and the adrenal cortex

  • 3

    It contains neuroendocrine neurons which synthesize and secrete vasopressin and corticotropin-releasing hormone (CRH)

    Paraventricular nucleus of the hypothalamus

  • 4

    CRH and vasopressin stimulate the _________ to secrete adrenocorticotropic hormone (ACTH), once known as corticotropin

    Anterior lobe of the pituitary gland

  • 5

    It produces glucocorticoid hormones (mainly cortisol in humans) in response to stimulation by ACTH. Glucocorticoids in turn, act back on the hypothalamus and pituitary (to suppress CRH and ACTH production) in a negative feedback cycle

    Adrenal cortex

  • 6

    Cortisol produced in the adrenal cortex works by _____ to inhibit both the hypothalamus and the pituitary gland

    Negative feedback

  • 7

    When cortisol inhibits the hypothalamus and pituitary, it reduces the secretion of______ and _____, and also directly reduces the cleavage of_______ into___ and ______.

    CRH and vasopressin; proopiomelanocortin (POMC) into ACTH and β-endorphins.

  • 8

    Epinephrine and norepinephrine (E/NE) are produced by the _____through sympathetic stimulation and the local effects of cortisol (_____ enzymes to make E/NE).

    adrenal medulla; upregulation

  • 9

    Epinephrine and norepinephrine (E/NE) will _____ give feedback to the _____ and _____ the breakdown of proopiomelanocortin (POMCs) into ACTH and β-endorphins.

    positively; pituitary; increase

  • 10

    Drugs of the Anterior Pituitary

    Leuprolide, Goserelin, Nafarelin, and Histrelin

  • 11

    -These agents used to ↓ production of gonadal steroids—androgen & estrogen -Prescribed for use in prostate cancer, endometriosis & precocious puberty

    Leuprolide, Goserelin, Nafarelin, and Histrelin

  • 12

    -CI—pregnancy & breastfeeding -AE—in women, hot flushes, sweating, decreased libido, depression & ovarian cysts -AE—in men, bone pain [initially], edema. gynecomastia, diminished libido, metabolic bone disease

    Leuprolide, Goserelin, Nafarelin, and Histrelin

  • 13

    Corticotropin releasing hormone [CRH] stimulates release of _____from pituitary

    ACTH

  • 14

    Stress ______; cortisol ______

    ↑ release of ACTH; ↓ ACTH release

  • 15

    MOA of Corticotropin releasing hormone [CRH]

    Hypothalamus releases CRH to stimulate ACTH in the anterior pituitary to convert cholesterol to pregnenolone in the adrenal cortex, which results in the synthesis of adrenal steroids and adrenal androgens

  • 16

    Discuss ACTH's limited medical use

    Mainly to help differentiate Addison’s disease from 2⁰ adrenal failure [caused by a pituitary issue]

  • 17

    AE of Corticotropin releasing hormone [CRH]

    None with short term use; with longer use s/e similar to using steroids chronically

  • 18

    Growth hormone releasing hormone [GHRH] stimulates release of ____; is inhibited by ______.

    GH; Somatostatin

  • 19

    This hormone stimulates cell proliferation, bone growth, lean muscle mass production, skin thickness and ↓ adiposity

    Growth hormone releasing hormone [GHRH]

  • 20

    MOA of Growth hormone releasing hormone [GHRH]

    GH effects exerted directly on its target organs, yet some effects mediated through insulin like growth factors 1 & 2

  • 21

    Used to treat GH deficiency in children; growth failure in Prader-Willi, HIV wasting & adults with documented low GH; used off label as “antiaging” hormone

    Growth hormone releasing hormone [GHRH]

  • 22

    Somatotropin given ____; stimulates _____ in the liver

    SQ or IM; IGF-1

  • 23

    AE of Growth hormone releasing hormone [GHRH]

    Edema, arthralgias, ↑ risk of DM

  • 24

    CI of Growth hormone releasing hormone [GHRH]

    Children with closed epiphyses, those with diabetic eye disease, patients with Prader-Willi that are obese

  • 25

    Somatostatin (GHRH) binds to receptors that suppress____ & ____ release; this hormone also suppress release of ______, ________ & _____.

    GH & TSH; insulin, glucagon & gastrin

  • 26

    Used to treat acromegaly & s/e of carcinoid tumors, _____ & ______are the synthetic versions of Somatostatin—depot injections given q4 weeks

    Octreotide & Lanreotide

  • 27

    AE of Octreotide & Lanreotide

    Diarrhea, abdominal pain, gas, nausea & steatorrhea

  • 28

    Hypothalamus releases GnRH in pulsed fashion to stimulate release of____&____ from anterior pituitary

    FSH & LH

  • 29

    Continuous release of ____ [thru use of synthetic versions] causes down regulation of the receptors & inhibits release of the gonadotropins

    GnRH

  • 30

    These regulate our gonadal steroid production. Used as prescriptions in infertility

    FSH/LH

  • 31

    Obtained from urine of post-menopausal women, contains both FSH & LH. Can be used exogenously in fertility treatments.

    hMG

  • 32

    Placental hormonal found in the urine of pregnant women. Acts like LH in fertility therapies.

    hCG

  • 33

    FSH obtained from postmenopausal women that has no LH in it, and is also used to treat infertility

    Urofollitropin

  • 34

    FSH products made by DNA recombinant technologies—for infertility

    Follitropin [α & β]

  • 35

    Made by DNA recombinant therapy identical to hCG—used in fertility therapies. These are given IM over 5-12 days—the ovarian follicle grows & matures. A round of hCG follows—ovulation then occurs.

    Choriogonadotropin α

  • 36

    AE Choriogonadotropin α

    Ovarian enlargement & possible hyperstimulation

  • 37

    Stimulates & maintains lactation; yet it ↓ sexual drive & reproductive functions, its secretion is inhibited by dopamine acting at D2 receptors

    Prolactin

  • 38

    ______& all antipsychotics that act as dopamine ______ will increase the secretion of prolactin

    Metoclopramide; antagonists

  • 39

    Hyperprolactinemia causes ____ & _____.

    galactorrhea & hypogonadism

  • 40

    For ↑ prolactin [not related to drugs], we prescribe _____ or _____.

    Bromocriptine or Cabergoline

  • 41

    Posterior pituitary hormones are not regulated by regulator or releasing hormones—they are made in the_____, then transported to the _______ & released in response to specific physiological changes [such as ∆ in plasma osmolarity]

    hypothalamus;posterior pituitary

  • 42

    How are the hormones of the Posterior Pituitary (Oxytocin & Vasopressin) adminstered?

    IV

  • 43

    Used to stimulate uterine contraction & to induce labor. Also causes milk ejection by contracting myoepithelial cells around the mammary alveoli.

    Oxytocin

  • 44

    Has both antidiuretic & vasopressor effects. In kidney it works to ↑ H2O permeability & reabsorption in collecting tubules. Used to treat diabetes insipidus. Can also be used in cardiac arrest & to ↓ bleeding in esophageal varices.

    Antidiuretic hormone [ADH]

  • 45

    AE of antidiuretic hormone [ADH]

    H2O intoxication & low Na+

  • 46

    Analog of ADH that has minimal renal effects—used largely as a pressor. Longer acting than ADH; used for DI and nocturnal enuresis. Given PO or nasally [no longer given nasally for enuresis in children r/t ↑ risk of seizures.

    Desmopressin [DDAVP]

  • 47

    -Regulates protein, fat and carbohydrate metabolism -Regulates cell metabolic rate -Regulates body heat production -Maintains growth hormone secretion and skeletal muscle maturation -Affects CNS development (fetal through 2 years of age) -Maintains cardiac rate, force and output -Maintains secretion of GI tract -Affects RR and oxygen utilization

    Principal function/actions of the thyroid gland

  • 48

    Measures your thyroid-stimulating hormone. This is usually the first test most providers recommend.

    TSH (thyroid-stimulating hormone)

  • 49

    Your pituitary gland makes TSH. It travels to your thyroid gland, stimulating it to produce thyroid hormones ___&____

    T3 and T4

  • 50

    This test serves as “early warning system” – often occurring before the actual level of thyroid hormones in the body becomes too high or too low

    TSH (thyroid-stimulating hormone)

  • 51

    Indicates that the thyroid gland is not making enough thyroid hormone (primary hypothyroidism)

    High TSH level

  • 52

    Usually indicates that the thyroid is producing too much thyroid hormone (hyperthyroidism)

    Low TSH level

  • 53

    Measures the amount of triiodothyronine in your blood. This hormone is one of two main hormones that your thyroid makes. Most useful in screening, diagnosis, and monitoring of hyperthyroidism

    T3 (or free T3) (triiodothyronine)

  • 54

    Measures the amount of thyroxine in your blood. Thyroxine is the other main type of hormone that your thyroid makes. Tests measuring free T4 – either a free T4 (FT4) or free T4 index (FTI) – more accurately reflect how the thyroid gland is functioning when checked with a TSH

    T4 (or free T4) (thyroxine)

  • 55

    The most common symptoms in adults are fatigue, lethargy, cold intolerance, weight gain, constipation, change in voice, and dry skin, but clinical presentation can differ with age and sex, among other factors. The standard treatment is thyroid hormone replacement therapy with levothyroxine.

    Clinical presentation and therapy for hypothyroidism

  • 56

    Is characterized by increased thyroid hormone synthesis and secretion from the thyroid gland

    Hyperthyroidism

  • 57

    Refers to the clinical syndrome of excess circulating thyroid hormones, irrespective of the source

    Thyrotoxicosis

  • 58

    Anti-thyroid medications include...

    Methimazole and propylthiouracil

  • 59

    Are used in symptomatic thyrotoxicosis and Grave's disease

    Beta blockers (propranolol)

  • 60

    Is a common finding in people with hyperthyroidism

    A high level of T-4 and a low level of TSH

  • 61

    Most common cause of hyperthyroidism - immune system disorder that results in the overproduction of thyroid hormones

    Graves disease

  • 62

    Symptoms include: Anxiety and irritability, A fine tremor of the hands or fingers, Heat sensitivity and an increase in perspiration or warm, moist skin, Weight loss, despite normal eating habits, Enlargement of the thyroid gland (goiter), Change in menstrual cycles, Erectile dysfunction or reduced libido, Frequent bowel movements, Bulging eyes, Fatigue, Thick, red skin usually on the shins or tops of the feet, Rapid or irregular heartbeat (palpitations), Sleep disturbance

    Grave's disease

  • 63

    Grave's disease treatment options:

    Beta-blockers (propranolol and metoprolol), Antithyroid medications (methimazole and propylthiouracil), Radioiodine therapy, and thyroidectomy

  • 64

    Happens when your thyroid gland releases a large amount of thyroid hormone in a short amount of time. It’s a rare complication of hyperthyroidism. This condition is a medical emergency and is life-threatening

    Thyroid storm

  • 65

    Having a high fever — a temperature between 104 degrees to 106 degrees Fahrenheit is common, Having a rapid heart rate (tachycardia) that can exceed 140 beats per minute, Feeling agitated, irritable and/or anxious, Delirium, Congestive heart failure, Loss of consciousness.

    Common symptoms of Thyroid Storm

  • 66

    Antithyroid medication (thionamides) to stop your thyroid from making new thyroid hormones, Iodine solution to stop your thyroid from releasing thyroid hormone, Beta-blockers to manage your symptoms, Bile acid sequestrants to prevent your gut from reabsorbing thyroid hormone, Acetaminophen and cooling blankets to lower your temperature, Respiratory treatment, such as supplemental oxygen.

    Medications and treatment therapies for Thyroid Storm

  • 67

    Undergoes hepatic metabolism with no active metabolites. Renal excretion is < 10%. The elimination half-life is approximately 5—9 hours. However, the intrathyroidal residence of this thioamide drug is roughly 20 hours, and the duration of action 40 hours, which allows once-daily dosing some patients.

    Pharmacokinetics of Methimazole

  • 68

    Rash, pruritis, and arthralgia; associated with agranulocytosis and hepatotoxicity

    Side Effects/Adverse Effects of Methimazole

  • 69

    Interactions with Methimazole

    May interact with blood thinners and digoxin

  • 70

    Greater risk of teratogenic effects in the first trimester of pregnancy

    CI for Methimazole

  • 71

    Preferred over PTU because of longer ½ life and once-daily dosing, and lower incidence of adverse effects

    Dosing Considerations for Methimazole

  • 72

    What is the thioamide drug? -Absorption: 75% -Distribution: 80 to 85% of the drug is bound to plasma proteins (lipoproteins and albumin are the major binding proteins), Vd 0.4 L/kg -Onset: 24 to 36 hours are necessary for a significant therapeutic effect. -Duration: 12 to 24 hours. -Half-life elimination: approximately 1 hour.

    Pharmacokinetics of Propylthiouracil

  • 73

    Rash, pruritis, and arthralgia; associated with agranulocytosis and hepatotoxicity (more severe with this drug), and more severe forms of liver injury (including acute liver failure)

    Side Effects/Adverse Effects of Propylthiouracil

  • 74

    Interactions with Propylthiouracil

    May interact with blood thinners and digoxin

  • 75

    Recommended during the first trimester of pregnancy due to a greater risk of teratogenic effects with methimazole

    Dosing Considerations for Propylthiouracil

  • 76

    BMI between 25-29.9

    overweight

  • 77

    BMI of 30 or more

    obese

  • 78

    BMI of 40 or more

    severe obesity

  • 79

    Childhood overweight is being at or above _____of weight for age

    85th percentile

  • 80

    Childhood obesity is a BMI at or above the _____ for a specific age

    95th percentile

  • 81

    AHA, ACC and Obesity Society [2015] state that weight loss intervention is indicated for:

    -BMI >25 and 1 or more CV weight related risk factor or condition -BMI >/= to 30, regardless of the presence of cardiometabolic risk factors -Waist circumference is a significant parameter that should be assessed in all overweight/obese patients -In the US, the cutoff is 40 inches for men and 35 inches for women [for Asian Americans the cut off is 5” less]

  • 82

    These are approved for short term use only [90 days] and include Diethylpropion [Tenuate] and Phentermine [Adipex-P]

    Anorexiants

  • 83

    Both agents ↑ norepinephrine [Phentermine also ↑ dopamine] & both inhibit the reuptake of NE [+/- Dp]; this ↑ in NE ↓appetite

    MOA of Anorexiants

  • 84

    Phentermine is excreted in kidney; Diethylpropion is metabolized in the liver, the active metabolites are excreted in kidney—these metabolites have a 4-8 hour ½ life

    Pharmacokinetics of Anorexiants

  • 85

    Controlled substances [S IV] b/c of potential for dependence; common SE—dry mouth, HA, insomnia, constipation; can ↑ BP

    AE of Anorexiants

  • 86

    -Avoid in those with uncontrolled BP, CV disease, arrhythmias, CHF or stroke hx -Contraindicated with other sympathomimetics [Sudafed, excess caffeine, etc.] & MAO inhibitors

    Anorexiants

  • 87

    -Pentatonic acid ester that inhibits gastric and pancreatic lipases, ↓ breakdown of fat -↓ fat absorption by 30%; main mechanism of weight loss—this loss of calories

    MOA of Orlistat [Xenical/Alli]

  • 88

    List Anorexiants

    Diethylpropion [Tenuate] Phentermine [Adipex-P]

  • 89

    List Lipase Inhibitors

    Orlistat [Xenical/Alli]

  • 90

    Taken with food that contains fat; minimal absorption; excreted in feces

    Pharmacokinetics of Lipase Inhibitors

  • 91

    Oily spotting, gas, interferes with absorption of fat soluble vitamins [A, E, D, K & β carotene]

    AE of Lipase Inhibitors

  • 92

    Pregnancy, chronic malabsorption, cholestasis

    CI for Lipase Inhibitors

  • 93

    Serotonin Agonists

    Lorcaserin [Belviq]

  • 94

    -Selectively binds to 2C serotonin receptor [5-HT2c] -Previous drugs of this class caused valve disease—thought to be linked to their effect on 5-HT 2B receptors

    Serotonin Agonists

  • 95

    With 5HT-2c receptor activation, stimulates pro-opiomelanocortin neurons, which activate melanocortin receptors, causing a ↓ in appetite

    MOA of Serotonin Agonists

  • 96

    Metabolized in liver—inactive metabolites are eliminated in the urine [not recommended in severe renal impairment]

    Pharmacokinetics of Serotonin Agonists

  • 97

    Nausea, headache, dry mouth, constipation, lethargy

    AE of Serotonin Agonists

  • 98

    -Rarely, mood changes and SI -Caution with use of other serotonergic agent—SNRIs, SSRIs, MAOIs—because of risk of NMS -Monitor patient for development of valvular heart disease—assess for new or ∆ in murmur -Avoid prescribing this agent in patients with hx of CHF, those with hx of known valve problems

    Considerations for Serotonin Agonists

  • 99

    -For weight loss—exact MOA is unknown -Naltrexone antagonizes various opioid receptors, while Bupropion inhibits neuronal uptake of NE & dopamine

    Naltrexone ER/Bupropion ER [Contrave]

  • 100

    Combination Agents

    Naltrexone ER/Bupropion ER [Contrave]